Ursodiol Capsule
Product Images NDC 70771-1524

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 70771-1524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (149e5f3a D75d 42b6 B7a6 641c02b7c8dd 01)

Chemical structure of ursodiol, the active ingredient in Ursodiol 300 mg capsules by Zydus Lifesciences Limited. The diagram shows the molecular structure including hydroxyl groups and carboxylic acid functional groups.*

FDA Label Image

Label (149e5f3a D75d 42b6 B7a6 641c02b7c8dd 02)

Ursodiol Capsules USP 300 mg oral capsules label showing the product name, strength, and form. The label states each capsule contains 300 mg of Ursodiol, with storage instructions and a note that the package is child-resistant. It is manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Lifesciences Limited. The package contains 100 capsules with a National Drug Code of 70771-1524-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.